Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2021 5
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean riedler l[au] (71 results)?
Comparison of Four SARS-CoV-2 Neutralization Assays.
Riepler L, Rössler A, Falch A, Volland A, Borena W, von Laer D, Kimpel J. Riepler L, et al. Vaccines (Basel). 2020 Dec 28;9(1):13. doi: 10.3390/vaccines9010013. Vaccines (Basel). 2020. PMID: 33379160 Free PMC article.
Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl.
Borena W, Bánki Z, Bates K, Winner H, Riepler L, Rössler A, Pipperger L, Theurl I, Falkensammer B, Ulmer H, Walser A, Pichler D, Baumgartner M, Schönherr S, Forer L, Knabl L, Würzner R, von Laer D, Paetzold J, Kimpel J. Borena W, et al. Among authors: riepler l. EBioMedicine. 2021 Aug;70:103534. doi: 10.1016/j.ebiom.2021.103534. Epub 2021 Aug 12. EBioMedicine. 2021. PMID: 34392147 Free PMC article.
High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl.
Knabl L, Mitra T, Kimpel J, Rössler A, Volland A, Walser A, Ulmer H, Pipperger L, Binder SC, Riepler L, Bates K, Bandyopadhyay A, Schips M, Ranjan M, Falkensammer B, Borena W, Meyer-Hermann M, von Laer D. Knabl L, et al. Among authors: riepler l. Commun Med (Lond). 2021;1(1):4. doi: 10.1038/s43856-021-00007-1. Epub 2021 Jun 30. Commun Med (Lond). 2021. PMID: 34870284 Free PMC article.
ADAM10 and ADAM17 promote SARS-CoV-2 cell entry and spike protein-mediated lung cell fusion.
Jocher G, Grass V, Tschirner SK, Riepler L, Breimann S, Kaya T, Oelsner M, Hamad MS, Hofmann LI, Blobel CP, Schmidt-Weber CB, Gokce O, Jakwerth CA, Trimpert J, Kimpel J, Pichlmair A, Lichtenthaler SF. Jocher G, et al. Among authors: riepler l. EMBO Rep. 2022 Jun 7;23(6):e54305. doi: 10.15252/embr.202154305. Epub 2022 May 8. EMBO Rep. 2022. PMID: 35527514 Free PMC article.
Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial.
Bánki Z, Mateus J, Rössler A, Schäfer H, Bante D, Riepler L, Grifoni A, Sette A, Simon V, Falkensammer B, Ulmer H, Neurauter B, Borena W; HEVACC Study Group, Krammer F, von Laer D, Weiskopf D, Kimpel J. Bánki Z, et al. Among authors: riepler l. EBioMedicine. 2022 Jun;80:104073. doi: 10.1016/j.ebiom.2022.104073. Epub 2022 May 23. EBioMedicine. 2022. PMID: 35617826 Free PMC article. Clinical Trial.